amiodarone has been researched along with Familial Periodic Paralysis in 2 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Junker, J | 1 |
| Haverkamp, W | 1 |
| Schulze-Bahr, E | 1 |
| Eckardt, L | 1 |
| Paulus, W | 1 |
| Kiefer, R | 1 |
| Jenkins, PL | 1 |
| Shaw, G | 1 |
2 other studies available for amiodarone and Familial Periodic Paralysis
| Article | Year |
|---|---|
Amiodarone and acetazolamide for the treatment of genetically confirmed severe Andersen syndrome.
Topics: Acetazolamide; Adolescent; Amiodarone; Anti-Arrhythmia Agents; Anticonvulsants; Child; Drug Therapy, | 2002 |
Psychosis in a patient with hyperkalemic periodic paralysis.
Topics: Adult; Amiodarone; Female; Humans; Paralyses, Familial Periodic; Prednisolone; Substance-Related Dis | 1990 |